quinuclidines has been researched along with Glioma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fiveash, JB; Nikolaev, A; Yang, ES | 1 |
| Affronti, ML; Allen, K; Desjardins, A; Friedman, HS; Healy, PN; Herndon, JE; Kirkpatrick, J; McSherry, F; Peters, KB; Vredenburgh, JJ; Woodring, S | 1 |
| Akutsu, H; Ishikawa, E; Matsuda, M; Matsumura, A; Takano, S; Yamamoto, T | 1 |
| Gossuin, A; Laduron, P; Maloteaux, JM; Trouet, A | 1 |
1 trial(s) available for quinuclidines and Glioma
| Article | Year |
|---|---|
Phase II study to evaluate the safety and efficacy of intravenous palonosetron (PAL) in primary malignant glioma (MG) patients receiving standard radiotherapy (RT) and concomitant temozolomide (TMZ).
Topics: Administration, Intravenous; Antineoplastic Agents; Chemoradiotherapy; Dacarbazine; Female; Glioma; Humans; Isoquinolines; Male; Middle Aged; Palonosetron; Quality of Life; Quinuclidines; Surveys and Questionnaires; Temozolomide | 2016 |
3 other study(ies) available for quinuclidines and Glioma
| Article | Year |
|---|---|
Combined Targeting of Mutant p53 and Jumonji Family Histone Demethylase Augments Therapeutic Efficacy of Radiation in H3K27M DIPG.
Topics: Amino Acid Substitution; Brain Stem Neoplasms; Cell Line, Tumor; Dose Fractionation, Radiation; Glioma; Histone Demethylases; Humans; Mutation, Missense; Quinuclidines; Radiation-Sensitizing Agents; Tumor Suppressor Protein p53 | 2020 |
Combination of Palonosetron, Aprepitant, and Dexamethasone Effectively Controls Chemotherapy-induced Nausea and Vomiting in Patients Treated with Concomitant Temozolomide and Radiotherapy: Results of a Prospective Study.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents, Alkylating; Aprepitant; Brain Neoplasms; Dacarbazine; Dexamethasone; Drug Therapy, Combination; Female; Glioma; Humans; Isoquinolines; Male; Middle Aged; Morpholines; Nausea; Palonosetron; Prospective Studies; Quinuclidines; Serotonin Antagonists; Temozolomide; Vomiting | 2016 |
Differentiation between ligand trapping into intact cells and binding on muscarinic receptors.
Topics: Animals; Biological Transport; Cell Line; Cell Membrane; Dexetimide; Glioma; Ligands; Lysosomes; N-Methylscopolamine; Neuroblastoma; Piperidines; Quinuclidines; Quinuclidinyl Benzilate; Receptors, Muscarinic; Scopolamine Derivatives | 1984 |